About

We are economists and thinkers from a range of disciplines who challenge conventional wisdom and advance ideas to better serve society.

Research

We develop research that challenges economic orthodoxy and serves society.

Articles

Commentary, analysis, interviews, and research summaries by INET-affiliated writers.

Video

Interviews, presentations and video series with provocative economic thinkers, public figures and students.

Podcast

Economics and Beyond with Rob Johnson, a podcast featuring interviews with some of the world’s most important thinkers, artists, and activists about the pressing issues of our time. The podcast is also available on all major podcasting platforms, such as Apple, Spotify, Google, and Podbean.

Education

Video series and courses for students and educators interested in exploring new economic thinking.

Events

To foster new economic thinking, we host convenings that gather together a diverse community of thinkers from different fields, countries, and schools of thought.

YSI

Through the Young Scholars Initiative (YSI), INET provides support to students, young professionals, or others who embrace new and critical ways of thinking about the economy. YSI fosters conversation among those who wish to engage with new economic thinking and connects young scholars to the Institute’s vast network of economists.

Topics

Browse all INET content organized by topic

Leeza Osipenko

Dr. Leeza Osipenko is the founder and CEO of Consilium Scientific, a non-profit advancing integrity in healthcare and clinical research. She was the former director of NICE Scientific Advice. Her current activities focus on health technology assessment, clinical trial integrity, evidence-based health policy, and rare disease research.

Dr. Leeza Osipenko is the founder and CEO of Consilium Scientific. Consilium Scientific is an independent nonprofit research organization working on clinical research integrity and evidence-based healthcare decision-making. It accepts no funding from manufacturers, laboratories or insurers for the assessment of specific technologies. Through the Evimeter project, supported by Arnold Ventures, it is developing a standardized framework for evaluating and communicating the evidence behind medical devices and diagnostics.

By this expert

The Fast Lane That Nobody Has to Take: Will Medicare learn more about the devices it pays for through the new RAPID pathway?

Article By Leeza Osipenko and Stanley Harvell-Smith | Oct 5, 2026

A new Medicare pathway promises faster, more predictable coverage for breakthrough medical devices. When participation is voluntary, however, and manufacturers can take other routes, the real test is not who enters the fast lane, but what Medicare learns about those who don’t.

Is That New Procedure Proven? MedTech Billing Codes and Evidence-Based Medicine

Article By Ekaterina Cleary and Leeza Osipenko | Mar 2, 2026

Introduced by the AMA in 2001, Category III CPT codes aimed to streamline financial reporting. Instead they became entangled in a politically driven, zero-sum reimbursement game.